Donor haptoglobin phenotype determines outcome following liver transplantation

Transplant International

Volumn 24, Issue 6, 2011, Pages 619-626

  Speeckaert, Reinhart ^a   Van Vlierberghe, Hans ^a   Troisi, Roberto ^a   De Bacquer, Dirk ^b   Speeckaert, Marijn M ^a   De Buyzere, Marc L ^a   Claeys, Lutgarde ^a   De Hemptinne, Bernard ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

genetic polymorphism; graft survival; haptoglobin; iron; liver transplantation; survival

Indexed keywords

FERRITIN; HAPTOGLOBIN; HAPTOGLOBIN 1-1; HAPTOGLOBIN 2-1; HAPTOGLOBIN 2-2; IRON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GEL ELECTROPHORESIS; GENOTYPE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; PRIORITY JOURNAL;

ADULT; END STAGE LIVER DISEASE; FEMALE; FERRITINS; GRAFT SURVIVAL; HAPTOGLOBINS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79955561857     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01246.x     Document Type: Article

References (48)

1. Nickerson P,. The impact of immune gene polymorphisms in kidney and liver transplantation. Clin Lab Med 2008; 28: 455.
2. Andus T, Holstege A,. Cytokines and the liver in health and disease. Effects on liver metabolism and fibrogenesis. Acta Gastroenterol Belg 1994; 57: 236.
3. Bowman BH,. Haptoglobin. In:, Bowman BH, ed. Hepatic Plasma Proteins. San Diego: Academic Press, 1998: pp. 679 -684.
4. Quaye IK,. Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 2008; 102: 735.
5. Buehler PW, Abraham B, Valleleian F, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin form peroxidative modification. Blood 2009; 113: 2578.
6. Nielsen MJ, Moestrup SK,. Receptor targeting of haemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009; 114: 764.
7. Eaton JW, Brandt P, Mahoney JR, Lee JT,. Haptoglobin: a natural bacteriostat. Science 1982; 215: 691.
8. El Ghmati SM, Van Hoeyveld EM, Van Strijp JAG, Ceuppens JL, Stevens EAM,. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol 1996; 156: 2542.
9. Snellman O, Sylvén B,. Haptoglobin acting as a natural inhibitor of cathepsin B activity. Nature 1967; 216: 1033.
10. Langlois M, Delanghe J,. Biological and clinical significance of haptoglobin polymorphism in man. Clin Chem 1996; 42: 1589.
11. Thomas L,. Haptoglobin/Hämopexin. In:, Thomas L, ed. Labor und Diagnose. 5th edn. TH-Books Verlagsgesellschaft GmbH, Frankfurt/Main, 1998: pp. 679 -684.
12. Langlois MR, Martin M-E, Boelaert JR, et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000; 46: 1619.
13. Van Vlierberghe H, Langlois M, Delanghe J, et al. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatosis patients. J Hepatol 2001; 35: 707.
14. Delanghe J, Van Acker J, Hemmer R, et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 1998; 12: 1027.
15. Van Vlierberghe H, Delanghe J,. Haptoglobin polymorphism and iron hemostasis. Clin Chem 2003; 49: 708.
16. Carter K, Bowen DJ, McCune CA, Worwood M,. Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis. Br J Haematol 2003; 122: 326.
17. Le Gac G, Ka K, Gourlaouen I, et al. HFE-related hemochromatosis: the haptoglobin 2-2 type has a significant but limited influence on phenotypic expression of the predominant p.C282Y homozygous genotype. Adv Hematol 2009 2009: 251701.
18. Wrighting DM, Andrews NC,. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006; 108: 3204.
19. Speeckaert R, Speeckaert MM, Padalko E, Claeys LR, Delanghe JR,. The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer. Clin Chem Lab Med 2009; 47: 826.
20. Quaye IK, Ababio G, Amoah AG,. Haptoglobin 2-2 phenotype is a risk factor for type 2 diabetes in Ghana. J Atheroscler Thromb 2006; 13: 90.
21. Bicho MC, Pereira da Silva A, Matos A, Silva RM, Bicho MD,. Sex steroid hormones influence the risk of cervical cancer: modulation by haptoglobin genetic polymorphism. Cancer Genet Cytogenet 2009; 191: 85.
22. Pavõn EJ, Muñoz P, Lario A, et al. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006; 6: S282.
23. Louagie H, Delanghe J, De Sombere I, De Buyzere M, Hauser P, Leroux-Roels G,. Haptoglobin polymorphism and immune response after hepatitis B vaccination. Vaccine 1993; 11: 1188.
24. Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B,. Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 1998; 36: 691.
25. Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG,. Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 1996; 25: 10.
26. Schmeling A, Bockholdt B, Schroder H, Geserick G,. Phenotype change in polymorphic plasma proteins following liver transplantation. Exp Clin Immunogenet 1996; 13: 78.
27. Kashiwagi N, Groth CG, Starzl TE,. Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med 1968; 128: 247.
28. Körmöczi GF, Säemann D, Buchta C, et al. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006; 36: 202.
29. Kristiansen M, Graversen J, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature 2001; 409: 198.
30. Smithies O,. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J 1955; 61: 629.
31. Delanghe J, Allcock K, Langlois M, Claeys L, De Buyzere M,. Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography. Clin Chim Acta 2000; 291: 43.
32. Fink P, Roemer M, Haeckel R, et al. Measurement of proteins with the Behring Nephelometer. A multicenter evaluation. J Clin Chem Clin Biochem 1989; 27: 261.
33. Denssem CG, Wassel J, Brooks NH, Yonan N, Keevil B,. Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy. J Heart Lung Transplant 2001; 20: 151.
34. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA,. Causes of death in autopsied liver transplantation patients. Mod Pathol 1998; 11: 37.
35. Garbino J, Romand JA, Pittet D, Giostra E, Mentha G, Suter P,. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Med Wkly 2005; 135: 587.
36. Shander A, Sazama K,. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion 2010; 50: 1144.
37. Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR,. Haptoglobin polymorphism and infection. Adv Clin Chem 2010; 50: 23.
38. Chow JK, Werner BG, Ruthazer R, Snydman DR,. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis 2010; 51: 16.
39. Santos M, De Sousa M,. In vitro modulation of T-cell surface molecules by iron. Cell Immunol 1994; 154: 498.
40. Cardier JE, Romano E, Soyano A,. T lymphocytes subsets in experimental iron overload. Immunopharmacol Immunotoxicol 1997; 19: 75.
41. Walker Jr EM, Walker SM,. Effects of iron overload on the immune system. Ann Clin Lab Sci 2000; 30: 354.
42. Langlois M, Delanghe J, Philippe J, et al. Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD 22. Eur J Clin Chem Clin Biochem 1997; 35: 199.
43. Arredouani M, Matthys P, Kasran A, Baumann H, Ceuppens JL,. Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies. Redox Rep 2001; 6: 369.
44. Langlois M, Delanghe J, Duprez D, De Buyzere M,. Oxidative stress is genetically influenced by the haptoglobin polymorphism. J Am Coll Cardiology 1998; 31: 145A.
45. Mazariegos GV, Reyes J, Webber SA, et al. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 2002; 73: 1342.
46. Fernandes H, Koneru B, Fernandes N, et al. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation 2002; 73: 1886.
47. Freeman Jr RB, Tran CL, Mattoli J, et al. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. NEMC TNF Study Group. New England Medical Center Tumor Necrosis Factor. Transplantation 1999; 67: 1005.
48. Tambur AR, Ortegel JW, Ben-Ari Z, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 2001; 71: 1475.